JEAN DELEAGE, PH.D. - Corporate Board Profile

RIGEL PHARMACEUTICALS INC

Filing Date	Source Excerpt
2006-04-25	Jean Deleage, Ph.D., age 65, joined us as a director in January 1997. Dr. Deleage is a founder and has been a managing director of Alta Partners, a venture capital firm investing in information technologies and life science companies since 1996. ... Dr. Deleage currently serves on the board of directors of Kosan Biosciences, Inc., IDM Pharma, Inc. and Alexza Pharmaceuticals, Inc.
2007-03-26	Jean Deleage, Ph.D., age 66, joined us as a director in January 1997. Dr. Deleage is a founder and has been a managing director of Alta Partners, a venture capital firm investing in information technologies and life science companies since 1996. ... The following table shows for the fiscal year ended December 31, 2006 certain information with respect to the compensation of all non-employee directors of the Company: DIRECTOR COMPENSATION FOR FISCAL 2006 ... Jean Deleage, Ph.D. Fees Earned or Paid in Cash ($) 23,000 Option Awards ($) 57,079 Total ($) 80,079
2008-04-08	Jean Deleage, Ph.D., age 67, joined us as a director in January 1997. ... The Compensation Committee comprises three directors: Drs. Moos and Deleage and Mr. Lyons. ... The following table shows for the fiscal year ended December 31, 2007 certain information with respect to the compensation of all non-employee directors of the Company: Jean Deleage, Ph.D. $45,000 Fees Earned or Paid in Cash, $56,969 Option Awards, Total $101,969.
2009-04-15	Jean Deleage, Ph.D., age 68, joined us as a director in January 1997. ... The following three directors are the members of the Audit Committee: Messrs. Goodwin and Renton and Dr. Sherwin, all of whom were on the Audit Committee for all of fiscal year 2008. ... The following three directors are the members of the Compensation Committee: Drs. Moos and Deleage and Mr. Lyons, all of whom were on the Compensation Committee for all of fiscal year 2008. ... The following three directors are the members of the Finance Committee: Mr. Gower and Drs. Deleage and Sherwin, each of whom were on the Finance Committee for all of fiscal year 2008. ... For services provided in 2008, each non-employee director of Rigel received a yearly retainer of $30,000, ... In the fiscal year ended December 31, 2008, the total cash compensation earned by non-employee directors was $194,760.
2010-04-12	Jean Deleage, Ph.D., age 69, joined us as a director in January 1997. The Nominating and Corporate Governance Committee concluded that Dr. Deleage should continue to serve as a director of Rigel in part due to his extensive experience and record of success as an investor in life sciences companies, bringing a distinct focus on stockholder return to the Board. Dr. Deleage is a founder and managing director of Alta Partners, a venture capital firm investing in information technologies and life science companies. Alta Partners was founded in 1996. In 1979, Dr. Deleage founded and served as managing partner of Burr, Egan, Deleage & Co., a venture capital firm in San Francisco and Boston. In 1971, Dr. Deleage became a member of Sofinnova's initial team, a venture capital organization in Paris, France, and in 1976 he formed Sofinnova, Inc., the U.S. subsidiary of Sofinnova. Dr. Deleage currently serves on the Boards of Directors of Innate Pharma SA and LifeCycle Pharma A/S. Dr. Deleage also serves on the boards of several private companies, including 7TM A/S, Nereus Pharmaceuticals, Inc., PamGene International B.V., Plexxikon, Inc. and Adiocia SAS. He served on the Boards of Directors of TorreyPines Therapeutics, Inc. from 2000 until 2009, Genedata AG from 2001 until 2006, and IDM Pharma Inc. from 2005 until 2009. Dr. Deleage holds a Master's degree in Electrical Engineering from the Ecole Superieure d'Electricite and a Ph.D. in Economics from the Sorbonne. In 1984, he was awarded the Ordre National du Merite, and in 1993, he was awarded the Legion of Honor from the French government in recognition of his career accomplishments. DIRECTOR COMPENSATION FOR FISCAL YEAR 2009 The following table shows for the fiscal year ended December 31, 2009 certain information with respect to the compensation of all non-employee directors of the Company: Jean Deleage, Ph.D. $48,500 Fees Earned or Paid in Cash Option Awards $59,159 Total $107,659
2011-04-04	Jean Deleage, Ph.D. (1) Until his death in March 2011. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2010: Jean Deleage, Ph.D. $48,000 Option Awards $75,390 Total $123,390